{
    "clinical_study": {
        "@rank": "40448", 
        "brief_summary": {
            "textblock": "Patients with bone metastases or bone lesions caused by breast cancer, multiple myeloma or\n      prostate cancer will be treated with IV Zometa in a 15 minute infusion. Pain will be\n      evaluated, as well as time in chair, quality of life and safety of Zometa."
        }, 
        "brief_title": "Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions", 
        "completion_date": {
            "#text": "November 2002", 
            "@type": "Actual"
        }, 
        "condition": [
            "Breast Cancer", 
            "Multiple Myeloma", 
            "Prostate Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Multiple Myeloma", 
                "Neoplasms, Plasma Cell", 
                "Prostatic Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  Signed informed consent\n\n          -  Greater than 18 years of age\n\n          -  Proof of breast cancer, multiple myeloma or prostate cancer\n\n          -  Diagnosis of at least one cancer-related bone lesion\n\n          -  If patient is of child-bearing potential, negative pregnancy test and on a medically\n             recognized form of contraception\n\n          -  ECOG performance status of 0,1 or 2\n\n          -  Ability to read, understand and write English or Spanish language\n\n          -  Normal renal function\n\n          -  Corrected serum calcium equal to or greater than 8mg/dl Exclusion Criteria\n\n          -  clinically symptomatic brain metastases\n\n          -  hypersensitivity to Zometa or other bisphosphonates\n\n          -  pregnant or lactating"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "500", 
        "firstreceived_date": "January 9, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00029224", 
            "org_study_id": "CZOL446EUS16"
        }, 
        "intervention": {
            "intervention_name": "zoledronic acid", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Zoledronic acid", 
                "Diphosphonates"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "bone lesions", 
            "breast cancer", 
            "multiple myeloma", 
            "prostate cancer", 
            "bone metastases", 
            "pain"
        ], 
        "lastchanged_date": "January 30, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Stockton", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95204"
                    }, 
                    "name": "Stockton Hematology Oncology Medical Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kissimmee", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34741"
                    }, 
                    "name": "Osceola Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89109"
                    }, 
                    "name": "Nevada Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albuquerque", 
                        "country": "United States", 
                        "state": "New Mexico", 
                        "zip": "87102"
                    }, 
                    "name": "New Mexico Oncology Hematology Consultants"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albuquerque", 
                        "country": "United States", 
                        "state": "New Mexico", 
                        "zip": "87102"
                    }, 
                    "name": "Hematology-Oncology Associates PC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medforo", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97504"
                    }, 
                    "name": "Hematology Oncology Associates, PC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23294"
                    }, 
                    "name": "Virginia Physicians, Inc"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Prospective, Multicenter, Open-label Clinical Evaluation of the Effect of IV Zoledronic Acid 4mg on PAIN, QUALITY OF LIFE and TIME IN INFUSION CHAIR in Breast Cancer, Multiple Myeloma, and Prostate Cancer Patients With Cancer-related Bone Lesions", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2002", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Pain score assessed by change from baseline", 
            "safety_issue": "No"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00029224"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Quality of life", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Time in infusion chair", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Safety assessed by adverse events (AEs)", 
                "safety_issue": "Yes"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2001", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2012"
    }, 
    "geocoordinates": {
        "Hematology Oncology Associates, PC": "42.327 -122.876", 
        "Hematology-Oncology Associates PC": "35.084 -106.651", 
        "Nevada Cancer Center": "36.115 -115.173", 
        "New Mexico Oncology Hematology Consultants": "35.084 -106.651", 
        "Osceola Cancer Center": "28.292 -81.408", 
        "Stockton Hematology Oncology Medical Group": "37.958 -121.291", 
        "Virginia Physicians, Inc": "37.541 -77.436"
    }
}